Bioanalysis and CMC Services

Kymos Group with 3 laboratories in Spain, Italy and Germany is devoted to providing any bioanalysis or CMC testing solution that you may need during the whole life cycle of your product research, development and quality control. We are experts in the bioanalysis and CMC of biologics, small molecules and nucleic acids.


Pre-Clinical and Clinical Services category


CMC Analysis and Quality Control category


Celltrion logo

“We are currently developing multiple new biosimilar projects and consider Kymos one of the best CROs in Europe for drug release and testing.”

Yong Suk Yang, Global QC Operation Team Manager, CELLTRION, INC

“We were positively impressed when Kymos reacted to our needs by investing in their stability capabilities, and now, two years down the line, with projects in full-swing, I can safely say that we made the right choice. In Kymos we have found a reliable, committed, trustworthy and professional partner.”

Dr. Dino Mangion, Head of Malta Operations, MEDICHEM/COMBINO PHARMA Ltd
Helm Logo

“Back in 2017 there weren’t many analytical CROs able to carry out Franz cell assays and Kymos’ pioneering work was pivotal for the registration of our product.”

Dr. Marius Strunk, Senior Pharmaceutical Development Manager, HELM AG
PharmaMar Logo

“Kymos offered superior historical expertise by being exposed to so many different clients, pharmacological compounds, and therapeutic areas. They addressed and anticipated very diverse problems.”

Dr. Pablo Avilés, PHARMAMAR S.A.

“I have had a long and fruitful experience with Kymos and have a huge interest in their participation owing to their reliability.”

Jaime Algorta, Medical Affairs Director , EXELTIS HEALTHCARE S.L.U.

“Prolytic is our analytical partner throughout the entire drug development process. Such a long and complex process requires a laboratory you can trust. Professional yet flexible, Prolytic accompanies us through the preclinical and clinical phases.”

TEchnical university Darmstadt_Logo

“Establishing robust miRNA methods for valuable results is tricky. The team at Prolytic have been a key collaboration partner. With their 30 years of experience in bioanalytics and broad know-how in different techniques, study types, and substance groups, we were able to quickly develop a reproducible and reliable analysis method for miRNAs.”

Dr. Meike Saul, Research Group Leader, Technische Universität Darmstadt


In case you are not able to find the bioanalytical or CMC method you need, please contact us. Our experts will check if we can develop the method for you or add it to our validated method list.

Get in touch

  • KOREA PHARM & BIO: Goyang, KR | 23-26 Apr 2024

  • BIO KOREA 2024: Seoul, KR | 08-10 May 2024

  • BIO International Convention: San Diego, US | 3-6 Jun 2024

  • Congrès POLEPHARMA Biotesting: Évreux, FR | 5-6 Jun 2024

  • AFI Symposium: Rimini, IT | 5-7 Jun 2024

  • BIOPLUS – INTERPHEX KOREA: Seoul, KR | 10-12 Jul 2024

  • Farmaforum: Madrid, ES | 25-26 Sep 2024

  • Biomarkers Europe 2024: Basel, CH | 30 Sep – 01 Oct 2024

  • CPHI 2024: Milan, IT | 8-10 Oct 2024

  • BIO-Europe Autumn: Stockholm, SE | 4-6 Nov 2024

  • European Bioanalysis Forum: Barcelona, ES | 20-22 Nov 2024

  • PharmaLab Congress: Düsseldorf, DE | 25-27 Nov 2024

  • I4ID 2024: Lyon, FR | 27-28 Nov 2024